Concentra Group Holdings Parent, Inc. SC 13D Filing

TL;DR

**Concentra Group Holdings Parent, Inc. SC 13D filed. Ownership change incoming.**

AI Summary

On December 3, 2024, Concentra Group Holdings Parent, Inc. filed an SC 13D, indicating a change in beneficial ownership. The filing involves Robert A. Ortenzio and Timothy F. Ryan, with addresses associated with Select Medical Corporation in Mechanicsburg, PA. The filing pertains to the Common Stock of Concentra Group Holdings Parent, Inc.

Why It Matters

This filing signals a potential shift in control or significant investment in Concentra Group Holdings Parent, Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — SC 13D filings often indicate significant stake-building or changes in control, which can lead to volatility.

Key Players & Entities

• Concentra Group Holdings Parent, Inc. (company) — Subject Company
• Robert A. Ortenzio (person) — Filer
• Timothy F. Ryan (person) — Person Authorized to Receive Notices
• Select Medical Corporation (company) — Associated Business Address
• Stephen M. Leitzell (person) — Copy Recipient (Legal Counsel)

FAQ

Key Financial Figures

• $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti

Filing Documents

• tm2430018d1_sc13d.htm (SC 13D) — 32KB
• 0001104659-24-125087.txt ( ) — 34KB

From the Filing

SC 13D 1 tm2430018d1_sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Concentra Group Holdings Parent, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 20603L102 (CUSIP Number) Timothy F. Ryan Concentra Group Holdings Parent, Inc. 5080 Spectrum Drive, Suite 1200W Addison, TX, 75001 (972) 364-8000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With copies to: Stephen M. Leitzell Dechert LLP 2929 Arch Street Philadelphia, PA 19104 Tel: (215) 994-2621 Fax: (215) 994-2222 November 25, 2024 (Date of Event which Requires Filing of this If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box . Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1 NAMES OF REPORTING PERSONS Robert A. Ortenzio 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF GROUP (See Instructions) (a) ¨ (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 5,513,054 8 SHARED VOTING POWER 1,710,973 9 SOLE DISPOSITIVE POWER 5,513,054 10 SHARED DISPOSITIVE POWER 1,710,973 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,224,027 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) ¨ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.7% (1) 14 TYPE OF REPORTING PERSON (See Instructions) IN (1) Based on 127,343,503 shares of the Company’s common stock outstanding as of November 25, 2024. Item 1. Security and Issuer . This statement on Schedule 13D (the “Statement”) relates to the common stock, par value $0.01 per share of Concentra Group Holdings Parent, Inc., a Delaware corporation (the “Company”), which has its principal executive office at 5080 Spectrum Drive, Suite 1200W, Addison, TX, 75001. Item 2. Identity and Background . (a) Name . The name of the Reporting Person is Robert A. Ortenzio. (b) Business Address . The business address of the Reporting Person is 4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055. (c) Occupation and Employment . The Reporting Person currently serves on the Board of Directors of the Company, The Reporting Person is also the Executive Chairman and Co-Founder of Select Medical Holdings Corporation. Select Medical Holdings Corporation is located at 4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055. (d) Criminal Proceedings . During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) Civil Proceedings . During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which the Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Citizenship . The Reporting Person is a citizen of the United States. Item 3. Source and Amount of Funds or Other Consideration . On November 25, 2024, as previously announced, Select Medical Holdings Corporation (“Select”) completed its spin-off (“Spin-Off”) of an aggregate 104,093,503 shares of the Company by means of a pro rata stock distribution to each of Select’s stockholders as of the close of business on November 18, 2024 (the “Record Date”). Based on the number of shares of Select’s common stock outstanding as of the

View Full Filing

View this SC 13D filing on SEC EDGAR